全文获取类型
收费全文 | 170532篇 |
免费 | 3596篇 |
国内免费 | 1860篇 |
专业分类
耳鼻咽喉 | 1715篇 |
儿科学 | 6273篇 |
妇产科学 | 2750篇 |
基础医学 | 21158篇 |
口腔科学 | 4193篇 |
临床医学 | 11122篇 |
内科学 | 32767篇 |
皮肤病学 | 3003篇 |
神经病学 | 9968篇 |
特种医学 | 3393篇 |
外国民族医学 | 1篇 |
外科学 | 26520篇 |
综合类 | 10348篇 |
一般理论 | 4篇 |
预防医学 | 9530篇 |
眼科学 | 3284篇 |
药学 | 17860篇 |
15篇 | |
中国医学 | 6528篇 |
肿瘤学 | 5556篇 |
出版年
2022年 | 1295篇 |
2021年 | 2674篇 |
2020年 | 1500篇 |
2019年 | 12796篇 |
2018年 | 12419篇 |
2017年 | 5737篇 |
2016年 | 1276篇 |
2015年 | 1370篇 |
2014年 | 2938篇 |
2013年 | 4537篇 |
2012年 | 2985篇 |
2011年 | 3112篇 |
2010年 | 2515篇 |
2009年 | 2451篇 |
2008年 | 2937篇 |
2007年 | 4054篇 |
2006年 | 4326篇 |
2005年 | 4178篇 |
2004年 | 3260篇 |
2003年 | 3391篇 |
2002年 | 3216篇 |
2001年 | 3198篇 |
2000年 | 3409篇 |
1999年 | 3087篇 |
1998年 | 3122篇 |
1997年 | 2482篇 |
1996年 | 2334篇 |
1995年 | 2668篇 |
1994年 | 2514篇 |
1993年 | 1936篇 |
1992年 | 1529篇 |
1991年 | 1525篇 |
1990年 | 1272篇 |
1989年 | 1020篇 |
1988年 | 1061篇 |
1987年 | 1005篇 |
1986年 | 846篇 |
1985年 | 5427篇 |
1984年 | 7305篇 |
1983年 | 5830篇 |
1982年 | 6278篇 |
1981年 | 5718篇 |
1980年 | 4917篇 |
1979年 | 4972篇 |
1978年 | 4068篇 |
1977年 | 3056篇 |
1976年 | 3530篇 |
1975年 | 2735篇 |
1974年 | 2527篇 |
1973年 | 2226篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
角膜移植为治疗角膜盲的主要手段,而角膜移植排斥则是决定角膜植片存活时间和病人术后视力的关键。角膜得益于其特殊的眼前节“免疫赦免”状态,使得角膜移植能够在众多器官移植中享有极低的排斥率,然而排斥反应发生的风险依然存在。当机体处于遗传物质异常的特殊状态时,宿主将通过宏观调控“免疫赦免”状态对植片的保护作用或受体对移植物排异产生的有害作用,延迟或促进角膜移植排斥反应的发生,进而影响移植物的存活时间和透明度。该文综述与角膜移植排斥相关的多种全身性遗传疾病,总结全身性遗传疾病对角膜移植排斥的影响,浅析其发生的病理生理学机制以及诊疗的特殊性。 相似文献
12.
Guo-Quan Shi Huajun Zhu & Zhen-Guo Yan 《Communications In Computational Physics》2022,31(4):1215-1241
A priori subcell limiting approach is developed for high-order flux reconstruction/correction procedure via reconstruction (FR/CPR) methods on two-dimensional unstructured quadrilateral meshes. Firstly, a modified indicator based on
modal energy coefficients is proposed to detect troubled cells, where discontinuities
exist. Then, troubled cells are decomposed into nonuniform subcells and each subcell has one solution point. A second-order finite difference shock-capturing scheme
based on nonuniform nonlinear weighted (NNW) interpolation is constructed to perform the calculation on troubled cells while smooth cells are calculated by the CPR
method. Numerical investigations show that the proposed subcell limiting strategy on
unstructured quadrilateral meshes is robust in shock-capturing. 相似文献
13.
14.
15.
Barouyr Baroudjian Dimitri Arangalage Stefania Cuzzubbo Baptiste Hervier Celeste Lebbé Gwenael Lorillon 《Expert review of anticancer therapy》2019,19(3):209-222
Introduction: Immune checkpoint inhibitors (ICI) are now a standard of care in the treatment of many cancers leading to durable responses in patients with metastatic disease. These agents are generally well tolerated but may lead to the occurrence of immune-related adverse events (irAEs). As any organ may be affected, clinicians should be aware of the broad range of clinical manifestations and symptoms and keep in mind that toxicities may occur late, at any point along a patient’s treatment course. Although the most common irAEs are rarely severe, some of them may be associated with great morbidity and even become life-threatening. The rate of occurrence, type and severity of irAEs may vary with the type of ICI; thus, grade 3 and 4 irAEs are reported in more than 55% of patients treated with the combination of ipilimumab 3 mg/kg and nivolumab 1 mg/kg.
Area covered: This review presents the management of irAEs resulting from checkpoint blockade, with a focus on rare irAEs.
Expert commentary: With the development of immuno-oncology and the expanding role of ICI, physicians have learnt to diagnose and treat most of the irAEs that can occur. This review provides an overview of current guidelines, previously published studies and our multidisciplinary team based practices. 相似文献
16.
17.
18.
19.
BackgroundTumor mutation burden (TMB) as a prognostic marker for immunotherapy has shown prognostic value in many cancers. However, there is no systematic investigation on TMB in papillary thyroid carcinoma (PTC).MethodsBased on the somatic mutation data of 487 PTC patients from The Cancer Genome Atlas (TCGA), TMB was calculated, and we classified the samples into high-TMB (H-TMB) and low-TMB (L-TMB) groups. Bioinformatics methods were used to explore the characteristics and potential mechanism of TMB in PTC.ResultsHigh TMB predicts shorter progression-free survival (PFS) (P < 0.001). TMB was positively correlated with age, stage, tumor size, metastasis, the male sex and tall cell PTC. Compared to the L-TMB group, the H-TMB group presented with lower immune cell infiltration, a higher proportion of tumor-promoting immune cells (M0 macrophages, activated dendritic cells and monocytes) and a lower proportion of antitumor immune cells (M1 macrophages, CD8+ T cells and B cells). Additionally, the characteristics displayed by different TMB groups were not driven by critical driver mutations such as BRAF and RAS.ConclusionsPTC patients with high TMB have a worse prognosis. By stratifying PTC patients according to their TMB, advanced PTC patients who are candidates for immunotherapy could be selected. 相似文献
20.